Ph. I Dasatinib/Protracted Temozolomide in Recurrent Malignant Glioma
This study has been withdrawn prior to enrollment.
(Study drug supplier withdrew support for the study. Study was withdrawn from the Duke IRB.)
Sponsor:
Annick Desjardins
Collaborator:
Bristol-Myers Squibb
Information provided by (Responsible Party):
Annick Desjardins, Duke University Medical Center
ClinicalTrials.gov Identifier:
NCT00734864
First received: May 4, 2008
Last updated: November 20, 2012
Last verified: November 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
| Study Status: | This study has been withdrawn prior to enrollment. |
|---|---|
| Estimated Study Completion Date: | June 2012 |
| Estimated Primary Completion Date: | June 2010 (Final data collection date for primary outcome measure) |